Cibc World Market Inc. Makes New $6.01 Million Investment in Humana Inc. $HUM

Cibc World Market Inc. acquired a new stake in shares of Humana Inc. (NYSE:HUM) during the second quarter, Holdings Channel.com reports. The firm acquired 15,120 shares of the insurance provider’s stock, valued at approximately $6,006,000.

A number of other large investors have also recently made changes to their positions in the company. Revolve Wealth Partners LLC purchased a new stake in Humana in the 4th quarter worth about $202,000. Woodline Partners LP boosted its position in shares of Humana by 460.0% during the first quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock valued at $2,697,000 after buying an additional 8,372 shares during the period. Sivia Capital Partners LLC boosted its position in shares of Humana by 53.7% during the second quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock valued at $316,000 after buying an additional 452 shares during the period. Cresset Asset Management LLC grew its stake in shares of Humana by 10.3% during the second quarter. Cresset Asset Management LLC now owns 2,369 shares of the insurance provider’s stock valued at $581,000 after buying an additional 222 shares during the last quarter. Finally, WINTON GROUP Ltd grew its stake in shares of Humana by 58.5% during the second quarter. WINTON GROUP Ltd now owns 2,381 shares of the insurance provider’s stock valued at $582,000 after buying an additional 879 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on HUM shares. HSBC downgraded Humana to a “hold” rating in a report on Thursday, July 30th. Oppenheimer reaffirmed an “outperform” rating and issued a $405.00 price objective on shares of Humana in a research report on Thursday, July 30th. Guggenheim increased their target price on Humana from $269.00 to $471.00 and gave the stock a “buy” rating in a research note on Thursday, July 30th. Royal Bank Of Canada lifted their target price on Humana from $246.00 to $415.00 and gave the stock a “sector perform” rating in a research report on Thursday, July 9th. Finally, Leerink Partners raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $513.00 target price for the company in a research note on Thursday, July 30th. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $403.91.

Humana Stock Up 0.6%

Shares of NYSE:HUM opened at $388.92 on Wednesday. The business’s 50 day moving average is $383.88 and its 200 day moving average is $285.00. The stock has a market cap of $46.70 billion, a P/E ratio of 36.79, a price-to-earnings-growth ratio of 2.20 and a beta of 0.72. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $428.88. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, beating analysts’ consensus estimates of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The business had revenue of $40.89 billion during the quarter, compared to analyst estimates of $40.58 billion. During the same period in the previous year, the company posted $6.27 EPS. Humana’s revenue was up 26.2% on a year-over-year basis. Sell-side analysts predict that Humana Inc. will post 9.12 EPS for the current year.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.